Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R-1929
2. R1929
3. Stresnil
1. 1649-18-9
2. Azaperon
3. Stresnil
4. Suicalm
5. Fluoperidol
6. Eucalmyl
7. Azeperone
8. Sedaperone Vet
9. R-1929
10. Azaperona
11. Azaperonum
12. Nsc 170976
13. 1-butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-
14. 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one
15. 1-(3-(4-fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine
16. R 1929
17. 4'-fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone
18. 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone
19. Nsc-170976
20. Azaperone For Veterinary Use
21. 1-(4-fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one
22. 1-butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-
23. Mls003106751
24. 19bv78ak7w
25. Chembl340211
26. Chebi:88301
27. 1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one
28. Mfcd00866692
29. Nsc170976
30. Ncgc00016590-01
31. Azaperone 100 Microg/ml In Acetonitrile
32. Butyrophenone, 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-
33. Cas-1649-18-9
34. Dsstox_cid_25361
35. Dsstox_rid_80826
36. Dsstox_gsid_45361
37. 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone
38. Azaperonum [inn-latin]
39. 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone
40. Butyrophenone, 4'-fluoro-4-(4-(2-pyridyl)-1-piperazinyl)-
41. Azaperona [inn-spanish]
42. Smr001233462
43. Ccris 1586
44. Sr-05000001712
45. Einecs 216-715-8
46. Brn 0565491
47. Unii-19bv78ak7w
48. Azaperone [usan:usp:inn:ban]
49. Stresnil (tn)
50. 1-one
51. Azaperone (usp/inn)
52. Azaperone [inn]
53. Azaperone [mi]
54. Azaperone [usan]
55. Prestwick0_001117
56. Prestwick1_001117
57. Prestwick2_001117
58. Prestwick3_001117
59. Spectrum2_001250
60. Spectrum3_001966
61. Azaperone [mart.]
62. Azaperone [usp-rs]
63. Bspbio_001254
64. Bspbio_003566
65. 5-23-03-00041 (beilstein Handbook Reference)
66. Mls002154163
67. Schembl121134
68. Spectrum1505332
69. Spbio_001160
70. Spbio_003117
71. Azaperone [green Book]
72. Bpbio1_001379
73. Azaperone [usp Impurity]
74. Dtxsid2045361
75. Kbio3_002914
76. Azaperone [usp Monograph]
77. Lamotrigine 5-n-?-d-glucuronide
78. Hms1571o16
79. Hms1922d20
80. Hms2090k03
81. Hms2093d03
82. Hms2098o16
83. Hms2230c17
84. Hms3369i10
85. Hms3652d15
86. Hms3715o16
87. Hms3885f11
88. Pharmakon1600-01505332
89. 1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one
90. Bcp12176
91. Hy-b1470
92. Zinc2596977
93. Tox21_110512
94. Azaperone 100 Microg/ml In Ethanol
95. Bbl011031
96. Bdbm50036733
97. Ccg-39158
98. Nsc758969
99. Pdsp1_000828
100. Pdsp2_000815
101. S4219
102. Stk802185
103. Akos005622715
104. Tox21_110512_1
105. Am84563
106. Cs-5158
107. Db11376
108. Ks-5204
109. Nsc-758969
110. Ncgc00016590-02
111. Ncgc00016590-03
112. Ncgc00016590-04
113. Ncgc00016590-06
114. Ncgc00016590-08
115. Ncgc00095171-01
116. Ncgc00095171-02
117. Ncgc00095171-03
118. Sy067157
119. Sbi-0206748.p001
120. Wln: T6n Dntj D3vr Df& A- Bt6nj
121. Ab00514057
122. Ft-0602908
123. Sw196387-3
124. Azaperone, Vetranal(tm), Analytical Standard
125. A16416
126. C73189
127. D02620
128. Ab00514057-06
129. Ab00514057_07
130. 649a189
131. A810604
132. L000791
133. J-010171
134. Q4832244
135. Sr-05000001712-1
136. Sr-05000001712-3
137. Brd-k45861246-001-05-0
138. Brd-k45861246-001-08-4
139. Azaperone, British Pharmacopoeia (bp) Reference Standard
140. {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone}
141. 4'-fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone
142. Azaperone, European Pharmacopoeia (ep) Reference Standard
143. 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-
144. Azaperone, United States Pharmacopeia (usp) Reference Standard
145. Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-}
146. 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butznone
147. 1-butanone,1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-
148. 1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one;azaperone
149. 1-butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-}
150. 1-(4-fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(azaperone)
Molecular Weight | 327.4 g/mol |
---|---|
Molecular Formula | C19H22FN3O |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 327.17469050 g/mol |
Monoisotopic Mass | 327.17469050 g/mol |
Topological Polar Surface Area | 36.4 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 390 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
48
PharmaCompass offers a list of Azaperone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Azaperone manufacturer or Azaperone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Azaperone manufacturer or Azaperone supplier.
PharmaCompass also assists you with knowing the Azaperone API Price utilized in the formulation of products. Azaperone API Price is not always fixed or binding as the Azaperone Price is obtained through a variety of data sources. The Azaperone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Azaperone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azaperone, including repackagers and relabelers. The FDA regulates Azaperone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azaperone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azaperone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azaperone supplier is an individual or a company that provides Azaperone active pharmaceutical ingredient (API) or Azaperone finished formulations upon request. The Azaperone suppliers may include Azaperone API manufacturers, exporters, distributors and traders.
click here to find a list of Azaperone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Azaperone DMF (Drug Master File) is a document detailing the whole manufacturing process of Azaperone active pharmaceutical ingredient (API) in detail. Different forms of Azaperone DMFs exist exist since differing nations have different regulations, such as Azaperone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Azaperone DMF submitted to regulatory agencies in the US is known as a USDMF. Azaperone USDMF includes data on Azaperone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Azaperone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Azaperone suppliers with USDMF on PharmaCompass.
A Azaperone CEP of the European Pharmacopoeia monograph is often referred to as a Azaperone Certificate of Suitability (COS). The purpose of a Azaperone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Azaperone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Azaperone to their clients by showing that a Azaperone CEP has been issued for it. The manufacturer submits a Azaperone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Azaperone CEP holder for the record. Additionally, the data presented in the Azaperone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Azaperone DMF.
A Azaperone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Azaperone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Azaperone suppliers with CEP (COS) on PharmaCompass.
Azaperone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azaperone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azaperone GMP manufacturer or Azaperone GMP API supplier for your needs.
A Azaperone CoA (Certificate of Analysis) is a formal document that attests to Azaperone's compliance with Azaperone specifications and serves as a tool for batch-level quality control.
Azaperone CoA mostly includes findings from lab analyses of a specific batch. For each Azaperone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azaperone may be tested according to a variety of international standards, such as European Pharmacopoeia (Azaperone EP), Azaperone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azaperone USP).